Willow Shah-Neville, Author at Labiotech.eu

About

Graduated with a degree in BA Journalism from the University of South Wales (Cardiff) in 2021. Shortly afterwards, I fell into content writing for a couple of different companies writing about different subjects including science, tech, crypto, lifestyle etc. But journalism is where my heart truly lies, and just before I landed my role here, I did a journalism internship with an online publication called TheSocialTalks, where I finally had an opportunity to get my journalistic work published. The rest is history and, having always been interested in biology and medical science, I’m now living my dream as a junior reporter here at Labiotech. Outside of work, hobbies include reading, TV & Film, cooking, travelling, eating out, and a decent amount of wine tasting…

Articles by Willow Shah-Neville

In Depth 5 Oct 2023

Saving lives with xenotransplantation: how biotechs are solving the transplant shortage crisis

On January 7, 2022, a surgery was performed on David Bennett to give him a new heart. But this was no ordinary transplant surgery. Instead of receiving a heart from a human donor, the 57-year-old, who did not qualify for a traditional transplant, received a pig heart. This surgery marked a historic breakthrough, becoming the […]

October 5, 2023 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 3 Oct 2023

Five impactful biotech companies to know in New York

New York – the place where people of all backgrounds come with hopes and dreams of making a better life for themselves – is just recently becoming a life sciences powerhouse, attracting many biotech companies, after a $1 billion public investment in the industry from the City of New York. This initiative, called LifeSci NYC, […]

October 3, 2023 - 8 minutesmins - By Willow Shah-Neville

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

The last few months have seen the obesity drug market soar, after new weight loss and diabetes drugs like Novo Nordisk’s Wegovy and Ozempic took the world by storm with their incredible efficacy at inducing weight loss. These new drugs belong to a class of medications called GLP-1 analogs (or incretin-based therapies), which work by […]

September 28, 2023 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 19 Sep 2023

Five biotech companies taking Los Angeles by storm

Known throughout history for being home to the iconic scene of Hollywood, in recent years Los Angeles has also become a thriving biotech hub, after years of playing second fiddle in the U.S. to the likes of South San Francisco and Boston. In this article, we take a look at five of the best Los […]

September 19, 2023 - 6 minutesmins - By Willow Shah-Neville

Best in Biotech 15 Sep 2023

Five latest advancements in NASH research

Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD) – a condition where fat builds up in the liver, potentially causing liver damage or cirrhosis. Despite the severity of the disease, and the fact that approximately 25% of U.S. adults have NAFLD, while 5% have NASH, there is yet to be […]

September 15, 2023 - 8 minutesmins - By Willow Shah-Neville

Startup Scout 13 Sep 2023

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

A healthy immune system is supposed to defend the body against disease and infection, but in autoimmune diseases, the immune system malfunctions, and instead attacks the body’s healthy cells, tissues, and organs. Despite recent progress in therapeutic options for autoimmune disorders, a significant unmet need remains, which is why Mysthera Therapeutics is aiming to take […]

September 13, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

With biotech funding trends always evolving, HSBC Innovation Banking’s inaugural Venture Healthcare Report lays out the trends seen in the first half (1H) of 2023, where valuations underwent a necessary reset, and venture capitalists emerged from their cautious stance, eventually embarking on a fresh wave of investments. However, an overall decline in investment was still […]

September 11, 2023 - 5 minutesmins - By Willow Shah-Neville

In Depth 8 Sep 2023

The rise of lab-grown dairy: a sustainable solution for the future

Recently, there has been a lot of talk surrounding cultivated meat, especially after Upside Foods and Good Meat received final U.S. Department of Agriculture (USDA) approval to sell lab-grown meat for the first time in the U.S.. And, although perhaps less talked about, cultivated – or lab-grown – dairy could also be set to take […]

September 8, 2023 - 8 minutesmins - By Willow Shah-Neville

Startup Scout 6 Sep 2023

Meet the startup developing novel cancer therapies from snake venom crotoxin

Snake venom is probably not the first thing that springs to mind when thinking about treatments or therapies, but the potential biotechnological and biomedical applications of animal venom components are actually widely recognized in scientific research. Now, Dublin-based startup Celtic Biotech is harnessing the potential of snake venom in an attempt to come up with […]

September 6, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 4 Sep 2023

The biggest private biotech investments in August 2023

The companies Genesis Therapeutics, ADARx Pharmaceuticals, and Abcuro bagged the biggest biotech investments in August 2023. Around the world, companies focused on immunology, genetic disorders, and metabolic disorders attracted the biggest funding rounds. Overall, quite a lot of biotech fundraising took place in August 2023. As always, there were some big rounds within the U.S. […]

September 4, 2023 - 3 minutesmins - By Willow Shah-Neville

Best in Biotech 30 Aug 2023

Five North Carolina biotech companies making their mark

North Carolina is home to Research Triangle Park, an R&D sanctuary situated between the cities of Raleigh and Durham, which just happens to be one of the biggest biotech hubs in the U.S., with a multitude of renowned companies. The southeastern state even rivals the likes of Boston, San Francisco, Los Angeles, and San Diego, […]

August 30, 2023 - 5 minutesmins - By Willow Shah-Neville

In Depth 22 Aug 2023

Lab-grown babies on the horizon: how IVG could transform human reproduction

Lately, there seems to have been a lot of talk about the possibility of ‘lab-grown babies’. Proper research into this area kicked off around a decade ago, and is still largely experimental in humans. But the technique used to potentially develop lab-grown babies could hold the power to provide a novel treatment option for human […]

August 22, 2023 - 8 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Willow Shah-Neville

About

Articles by Willow Shah-Neville

Saving lives with xenotransplantation: how biotechs are solving the transplant shortage crisis

Five impactful biotech companies to know in New York

Obesity drug success sparks biotech buying spree

Five biotech companies taking Los Angeles by storm

Five latest advancements in NASH research

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

The rise of lab-grown dairy: a sustainable solution for the future

Meet the startup developing novel cancer therapies from snake venom crotoxin

The biggest private biotech investments in August 2023

Five North Carolina biotech companies making their mark

Lab-grown babies on the horizon: how IVG could transform human reproduction

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Willow Shah-Neville

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!